Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours

NCT01867073 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01867073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01867073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2011
Completion date
May 31, 2015
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors